Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation
- 12 December 2002
- journal article
- case report
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 30 (12) , 967-970
- https://doi.org/10.1038/sj.bmt.1703763
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Invasive aspergillosis in haematological malignancies: Clinical findings and management for intensive chemotherapy completionAmerican Journal of Hematology, 2001
- Case Reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancyMycoses, 2001
- Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validationBlood, 2001
- Antifungal activity of the new azole UK‐109, 496 (voriconazole)Mycoses, 1999
- Impact of previous aspergillosis on the outcome of bone marrow transplantation.Clinical Infectious Diseases, 1998
- Invasive AspergillosisClinical Infectious Diseases, 1998
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Invasive Fungal Disease in Adults Undergoing Remission-Induction Therapy for Acute Myeloid Leukemia: The Pathogenetic Role of the Antileukemic RegimenClinical Infectious Diseases, 1995
- An approach to intensive antileukemia therapy in patients with previous invasive aspergillosisThe American Journal of Medicine, 1988
- Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia undergoing multiple courses of intensive chemotherapyThe American Journal of Medicine, 1988